Atlas Trials

Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR

Clinical trial NCT03940131 · UNKNOWN

Trial details

NCT number
NCT03940131
Sponsor
King Abdullah Medical City
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2020-06-10
Primary completion
2022-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.